Screening and management of hypothyroidism in pregnancy: results of an Asian survey.

摘要: Maternal hypothyroidism in pregnancy is associated with several adverse outcomes. The American Thyroid Association and the Endocrine Society Guidelines for management of thyroid diseases were published 2011 2012, respectively; however, impact guidelines routine clinical practice unknown. We therefore carried out a survey to study current practices screening pregnancy. collected completed questionnaire based on case scenarios from 321 members Asia-Oceania Thyrpid (AOTA). Responses 310 clinician (from 21 Asian countries) analyzed. For woman planning pregnancy, 54% favored testing function before adjusting dose, whilst 32% recommended increasing dose L-thyroxine (L-T₄) as soon confirmed. pregnant newly diagnosed overt hypothyroidism, most responders initiated full L-T₄. One half used serum TSH free T₄ monitor Although target tests that aimed achieve L-T₄ was inconsistent, but majority aim keep within trimester specific range. Twenty-one % or their institutions screened all women dysfunction, 66% performed targeted only high-risk group, 13% did not carry systemic screening. Majority recommendations major professional societies; there wide variation treatment during Asia.